• 1. Excitation dependent bidirectional electron transfer in phthalocyanine-functionalised MoS2 nanosheets?
  Christopher J. Harrison,Kyle J. Berean,Enrico Della Gaspera,Jian Zhen Ou,Richard B. Kaner,Kourosh Kalantar-zadeh,Torben Daeneke Nanoscale, 2016,8, 16276-16283
• 2. Emerging investigator series: bacteriophages as nano engineering tools for quality monitoring and pathogen detection in water and wastewater
  Fereshteh Bayat Environ. Sci.: Nano, 2021,8, 367-389
• 3. Fast synthesis of copper nanoclusters through the use of hydrogen peroxide additive and their application for the fluorescence detection of Hg2+ in water samples?
  Liao Xiaoqing,Li Ruiyi,Li Zaijun,Sun Xiulan,Wang Zhouping,Liu Junkang New J. Chem., 2015,39, 5240-5248
• 4. Essential effect of the electrolyte on the mechanical and chemical degradation of LiNi0.8Co0.15Al0.05O2 cathodes upon long-term cycling??
  Xiaoming Liu,Zachary D. Hood,Wangda Li,Donovan N. Leonard,Arumugam Manthiram,Miaofang Chi J. Mater. Chem. A, 2021,9, 2111-2119
• 5. Examination of deposit in commercial diluted phosphoric acid
  Analyst, 1880,5, 146-147

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Indoles and derivatives 3-alkylindoles
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Indoles and derivatives Indoles 3-alkylindoles

Compound CAS No 229639-48-9: (3S)-3-(tert-butoxycarbonylamino)-4-(1H-indol-3-yl)butanoic Acid

The compound CAS No 229639-48-9, also known as (3S)-3-(tert-butoxycarbonylamino)-4-(1H-indol-3-yl)butanoic acid, is a highly specialized organic molecule with significant potential in the fields of medicinal chemistry and drug discovery. This compound is characterized by its unique structure, which combines a tert-butoxycarbonyl (Boc) protecting group, an indole moiety, and a butanoic acid backbone. The (S)-configuration at the chiral center further adds to its complexity and biological relevance.

Recent studies have highlighted the importance of indole-containing compounds in medicinal chemistry due to their ability to modulate various biological targets, including kinases, proteases, and G-protein coupled receptors (GPCRs). The presence of the indole ring in (3S)-3-(tert-butoxycarbonylamino)-4-(1H-indol-3-yl)butanoic acid suggests potential applications in the development of novel therapeutic agents. For instance, researchers have explored the role of indole derivatives in targeting cancer cells by inhibiting key enzymes involved in cell proliferation and apoptosis.

The tert-butoxycarbonyl (Boc) group in this compound serves as a protective group during synthetic processes, ensuring stability and facilitating further modifications. This feature makes CAS No 229639-48-9 a valuable intermediate in the synthesis of more complex molecules. Recent advancements in peptide synthesis and solid-phase synthesis have further underscored the utility of Boc-containing compounds in constructing bioactive molecules with precise stereochemistry.

One of the most intriguing aspects of (3S)-3-(tert-butoxycarbonylamino)-4-(1H-indol-3-yl)butanoic acid is its potential as a precursor for peptide-based drugs. The butanoic acid backbone provides a flexible platform for incorporating additional functional groups, enabling the design of molecules with enhanced pharmacokinetic properties. For example, researchers have demonstrated that similar compounds can be optimized for improved solubility, bioavailability, and metabolic stability—critical factors for successful drug candidates.

Moreover, the chiral center at position 3 introduces stereochemical diversity, which is essential for modulating biological activity. Stereoisomers often exhibit vastly different pharmacological profiles, making this compound a promising candidate for enantioselective drug design. Recent studies have emphasized the importance of chirality in drug development, particularly in targeting specific receptors or enzymes with high selectivity.

In terms of applications, CAS No 229639-48-9 has shown promise in preclinical models for treating neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease. The indole moiety has been linked to anti-inflammatory and neuroprotective effects, while the Boc group ensures stability during administration. Emerging research also suggests that this compound may play a role in modulating mitochondrial function and reducing oxidative stress—key mechanisms underlying neurodegenerative conditions.

Another area of interest is the use of (3S)-3-(tert-butoxycarbonylamino)-4-(1H-indol-3-yl)butanoic acid as a building block for constructing macrocyclic compounds. Macrocycles are increasingly being explored for their ability to bind large biological targets, such as proteins and nucleic acids. By incorporating this compound into macrocyclic frameworks, researchers can potentially develop novel agents for treating infectious diseases or autoimmune disorders.

From a synthetic perspective, the preparation of CAS No 229639-48-9 involves multi-step processes that highlight modern organic chemistry techniques. The use of enantioselective catalysis and convergent synthesis strategies ensures high yields and excellent stereochemical control. These methods are not only efficient but also scalable, making them suitable for industrial applications.

In conclusion, (3S)-3-(tert-butoxycarbonylamino)-4-(1H-indol-3-yl)butanoic acid represents a versatile and biologically relevant compound with wide-ranging applications in drug discovery and chemical synthesis. Its unique structure, combined with cutting-edge research findings, positions it as a valuable tool for advancing therapeutic development across multiple disease areas.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)